Science
-
Research updates, March 10
A large retrospective cohort study found significant healthcare cost increases for Long COVID over five years. The study was shared as a preprint in medRxiv and included the records of over 143,000 people.
-
Research updates, March 3
Researchers identified high levels of cytokine interferon gamma (IFN-γ) in white blood cells as a potential biomarker for Long COVID. The small study, published in Science Advances, found that symptoms improved when production of IFN-γ (a molecule that plays an important role in immune response) decreased.
-
Research updates, February 24
SARS-C0V-2 reinfections significantly increase the risk of Long COVID in children, a new National Institutes of Health (NIH) RECOVER study found.
-
Research updates, February 17
A new review in Dovepress states that Long COVID, myalgic encephalomyelitis (ME), and postural orthostatic tachycardia syndrome (POTS) should be classified as neuroimmune disorders.
-
Research updates, February 10
A large study recently connected “chronic absenteeism” to pediatric Long COVID, further disproving the “immunity debt” talking points from pundits earlier in the pandemic.
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
One NIH study will test low-dose naltrexone, while other upcoming trials will test larozitide and taurine.
-
Research updates, February 3
The Food and Drug Administration (FDA) has granted expanded access to the stem cell infusion RegeneCyte for Long COVID.
-
Research updates, January 27
A large prospective cohort study published in Infectious Diseases found that a majority of people with Long COVID did not recover.
-
New RECOVER-TLC trials won’t enroll until summer. Nearly two years after the program’s launch.
The RECOVER-Treating Long COVID initiative is set to begin enrolling participants in new clinical trials this summer, which will mark nearly two years after the National of Institutes of Health (NIH) effort launched with promises to deliver greater urgency for this chronic disease impacting tens of millions of Americans.
-
Research updates, January 20
A new study in eBioMedicine found neurological Long COVID symptoms were associated with increased pTau-181 levels, a marker of brain inflammation that has been tied to Alzheimer’s disease.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
Where have all the Long COVID clinics gone?
-
National COVID-19 trends, March 10
-
Research updates, March 10
-
My child and I both have Long COVID. Even in COVID-aware spaces, we are excluded because of their pre-existing disability.
-
Two new books help children understand how Long COVID impacts their family members
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance